ADMP Adamis Pharmaceuticals Corporat

4.05
+0.10  (3%)
Previous Close 3.95
Open 4.00
Price To book 3.43
Market Cap 91.67M
Shares 22,634,000
Volume 589,926
Short Ratio 6.53
Av. Daily Volume 503,039

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued March 27 2015. CRL issued again June 6, 2016. NDA resubmission announced December 16, 2016. NDA acceptance announced January 19, 2017. No PDUFA date announced. PDUFA date estimate June 15, 2017 using 6-month time frame from resubmission.
Epinephrine Pre-filled Syringe (PFS)
Emergency treatment of anaphylaxis.
Phase 3 IND to be submitted 1H 2017.
APC-3000
Allergic Rhinitis
Phase 3 planned
APC-1000
Asthma/COPD